The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II study assessing an optimized schedule of oregovomab (O) anti-CA125 vaccination with carboplatin paclitaxel (CP) relative to CP alone in front-line treatment of optimally cytoreduced stage III/IV ovarian cancer (EOC).
 
Gabriella Ferrandina
No Relationships to Disclose
 
Patricia S. Braly
Speakers' Bureau - Clovis Oncology; Myriad Genetics; Roche
Research Funding - AstraZeneca; Janssen; PharmaMar; Tesaro
 
Corrado Terranova
No Relationships to Disclose
 
Vanda Salutari
No Relationships to Disclose
 
Caterina Ricci
No Relationships to Disclose
 
Francesco Raspagliesi
No Relationships to Disclose
 
Domenica Lorusso
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche
Research Funding - PharmaMar
Travel, Accommodations, Expenses - PharmaMar; Roche
 
Pierluigi Benedetti Panici
No Relationships to Disclose
 
Paolo Scollo
No Relationships to Disclose
 
Francesco Plotti
No Relationships to Disclose
 
Molly Brewer
No Relationships to Disclose
 
Michael W. Method
Stock and Other Ownership Interests - RainTree Oncology Services
Consulting or Advisory Role - Clovis Oncology
Speakers' Bureau - Clovis Oncology
Research Funding - Tesaro
Travel, Accommodations, Expenses - Immunogen
 
Robert W. Holloway
Speakers' Bureau - AstraZeneca; Clovis Oncology; Intuitive Surgical; Janssen
 
Madi Madiyalakan
Employment - Oncobiologics; Quest Diagnostics
Leadership - Oncobiologics; Quest Diagnostics
Stock and Other Ownership Interests - Oncobiologics; Quest Diagnostics
 
Christopher F. Nicodemus
Stock and Other Ownership Interests - Quest Diagnostics
Consulting or Advisory Role - Hemispherx Biopharma; Oncobiologics; Quest Diagnostics
 
Sergio L. Pecorelli
No Relationships to Disclose
 
Giovanni Scambia
No Relationships to Disclose
 
Roberto Angioli
No Relationships to Disclose